Symbol
GDTC on Nasdaq
Investment type
Equity - Shares of Stock
Class
Ordinary Shares, no par value per share
Latest Disclosed Ownership
1.31M shares
Security Ownership
11.3%

mDR LTD ownership in CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC)

2025-03-24 - mDR LTD has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.31M shares of CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC). This represents 11.3% percent ownership of the company.